File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0003-9969(94)00195-H
- Scopus: eid_2-s2.0-0029315235
- PMID: 7677606
- WOS: WOS:A1995RE36200019
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Modulation of the anti-Candida activity of apo-lactoferrin by dietary sucrose and tunicamycin in vitro
Title | Modulation of the anti-Candida activity of apo-lactoferrin by dietary sucrose and tunicamycin in vitro |
---|---|
Authors | |
Keywords | Candida albicans Candida krusei lactoferrin sucrose tunicamycin |
Issue Date | 1995 |
Publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/archoralbio |
Citation | Archives Of Oral Biology, 1995, v. 40 n. 6, p. 581-584 How to Cite? |
Abstract | The sensitivity to apo-lactoferrin (apo-LF) of two oral isolates each of Candida albicans and C. krusei preincubated in either sucrose- or tunicamycin-supplemented media was investigated. Known apo-LF-sensitive isolates of both C. albicans and C. krusei demonstrated significantly increased resistance to apo-LF when preincubated in sucrose-supplemented media, but such preincubation had no effect on an apo-LF-resistant isolate of C. albicans, irrespective of the sugar concentration in the medium. Surprisingly, an apo-LF-resistant isolate of C. krusei demonstrated increased susceptibility to apo-LF when preincubated in sucrose. Further, when preincubated with tunicamycin, a chemical that interferes with candidal cell-wall formation, the susceptibility to apo-LF of the resistant isolates increased significantly. These results, when extrapolated in vivo, imply that dietary sucrose may diminish the anticandidal potency of salivary lactoferrin. However, the aberrant behaviour of a single isolate of C. krusei under these circumstances is possibly due to the different cell-wall structure of this yeast and needs to be further investigated. |
Persistent Identifier | http://hdl.handle.net/10722/153931 |
ISSN | 2023 Impact Factor: 2.2 2023 SCImago Journal Rankings: 0.562 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nikawa, H | en_US |
dc.contributor.author | Samaranayake, LP | en_US |
dc.contributor.author | Hamada, T | en_US |
dc.date.accessioned | 2012-08-08T08:22:21Z | - |
dc.date.available | 2012-08-08T08:22:21Z | - |
dc.date.issued | 1995 | en_US |
dc.identifier.citation | Archives Of Oral Biology, 1995, v. 40 n. 6, p. 581-584 | en_US |
dc.identifier.issn | 0003-9969 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/153931 | - |
dc.description.abstract | The sensitivity to apo-lactoferrin (apo-LF) of two oral isolates each of Candida albicans and C. krusei preincubated in either sucrose- or tunicamycin-supplemented media was investigated. Known apo-LF-sensitive isolates of both C. albicans and C. krusei demonstrated significantly increased resistance to apo-LF when preincubated in sucrose-supplemented media, but such preincubation had no effect on an apo-LF-resistant isolate of C. albicans, irrespective of the sugar concentration in the medium. Surprisingly, an apo-LF-resistant isolate of C. krusei demonstrated increased susceptibility to apo-LF when preincubated in sucrose. Further, when preincubated with tunicamycin, a chemical that interferes with candidal cell-wall formation, the susceptibility to apo-LF of the resistant isolates increased significantly. These results, when extrapolated in vivo, imply that dietary sucrose may diminish the anticandidal potency of salivary lactoferrin. However, the aberrant behaviour of a single isolate of C. krusei under these circumstances is possibly due to the different cell-wall structure of this yeast and needs to be further investigated. | en_US |
dc.language | eng | en_US |
dc.publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/archoralbio | en_US |
dc.relation.ispartof | Archives of Oral Biology | en_US |
dc.subject | Candida albicans | - |
dc.subject | Candida krusei | - |
dc.subject | lactoferrin | - |
dc.subject | sucrose | - |
dc.subject | tunicamycin | - |
dc.subject.mesh | Apoproteins - Pharmacology | en_US |
dc.subject.mesh | Candida - Drug Effects | en_US |
dc.subject.mesh | Candida Albicans - Drug Effects | en_US |
dc.subject.mesh | Cell Membrane Permeability - Drug Effects | en_US |
dc.subject.mesh | Cell Wall - Drug Effects | en_US |
dc.subject.mesh | Culture Media | en_US |
dc.subject.mesh | Dietary Carbohydrates - Pharmacology | en_US |
dc.subject.mesh | Drug Interactions | en_US |
dc.subject.mesh | Drug Resistance, Microbial | en_US |
dc.subject.mesh | Extracellular Matrix - Drug Effects | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Lactoferrin - Pharmacology | en_US |
dc.subject.mesh | Sucrose - Pharmacology | en_US |
dc.subject.mesh | Tunicamycin - Pharmacology | en_US |
dc.title | Modulation of the anti-Candida activity of apo-lactoferrin by dietary sucrose and tunicamycin in vitro | en_US |
dc.type | Article | en_US |
dc.identifier.email | Samaranayake, LP:lakshman@hku.hk | en_US |
dc.identifier.authority | Samaranayake, LP=rp00023 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0003-9969(94)00195-H | - |
dc.identifier.pmid | 7677606 | - |
dc.identifier.scopus | eid_2-s2.0-0029315235 | en_US |
dc.identifier.hkuros | 3580 | - |
dc.identifier.hkuros | 9093 | - |
dc.identifier.volume | 40 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.spage | 581 | en_US |
dc.identifier.epage | 584 | en_US |
dc.identifier.isi | WOS:A1995RE36200019 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Nikawa, H=7006724162 | en_US |
dc.identifier.scopusauthorid | Samaranayake, LP=7102761002 | en_US |
dc.identifier.scopusauthorid | Hamada, T=7401759268 | en_US |
dc.identifier.issnl | 0003-9969 | - |